It has been reported that GLP-1 alleviates diabetic kidney disease by significantly decreasing urinary albumin and ameliorating renal pathological changes in vivo, and improves autophagy through mTOR signaling pathway (Yang et al., 2020). The gene discussed is GLP1R; the disease is diabetic kidney disease.